Skip to main content

Navigation group

Type at least 3 characters
566 articles

Articles

Original Research

Published on 27 Mar 2018

The Selective Angiotensin II Type 2 Receptor Agonist, Compound 21, Attenuates the Progression of Lung Fibrosis and Pulmonary Hypertension in an Experimental Model of Bleomycin-Induced Lung Injury

in Respiratory Physiology and Pathophysiology

  • Anandharajan Rathinasabapathy
  • Alana Horowitz
  • Kelsey Horton
  • Ashok Kumar
  • Santhi Gladson
  • Thomas Unger
  • Diana Martinez
  • Gaurav Bedse
  • James West
  • Mohan K. Raizada
The Selective Angiotensin II Type 2 Receptor Agonist, Compound 21, Attenuates the Progression of Lung Fibrosis and Pulmonary Hypertension in an Experimental Model of Bleomycin-Induced Lung Injury
Frontiers in Physiology
doi 10.3389/fphys.2018.00180
  • 9,923 views
  • 52 citations